Involved site radiation therapy for the treatment of early-stage Hodgkin lymphoma in adolescents and young adults

Radiation therapy technology has permitted the development of new treatment planning techniques. Involved field, involved node, and involved site radiotherapy fields are discussed and compared. Indications for and implications of combined modality therapy are examined, particularly as pertinent to the adolescent and young adult population.

• Publication year

  2015

• Venue

  Clinical Oncology in Adolescents and Young Adults

• Publication date

  2015-10-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.2147/COAYA.S70370PMID 26767184PMCID 4708267
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma.

  2016cited by this paper
• Expert radiation oncologist interpretations of involved-site radiation therapy guidelines in the management of Hodgkin lymphoma.

  2015cited by this paper
• Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma.

  2015cited by this paper
• Evidence-based focused review of the role of radiation therapy in the treatment of early-stage Hodgkin lymphoma.

  2015cited by this paper
• Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.

  2015cited by this paper
• Implementation of contemporary radiation therapy planning concepts for pediatric Hodgkin lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.

  2015cited by this paper
• Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents

  2015cited by this paper
• Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both?

  2015cited by this paper
• Individual prediction of heart failure among childhood cancer survivors.

  2015cited by this paper
• The new therapeutical scenario of Hodgkin lymphoma.

  2015cited by this paper
• The impact of involved node, involved field and mantle field radiotherapy on estimated radiation doses and risk of late effects for pediatric patients with Hodgkin lymphoma

  2014cited by this paper
• Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).

  2014cited by this paper
• ACR appropriateness Criteria® pediatric Hodgkin lymphoma

  2014cited by this paper
• Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.

  2014cited by this paper
• Treatment of Hodgkin lymphoma: a 50-year perspective.

  2014cited by this paper
• Safety and Early Efficacy in an Ongoing Pilot Study of Brentuximab Vedotin and AVD Chemotherapy Followed By 30 Gray Involved-Site Radiotherapy for Newly Diagnosed, Early Stage, Unfavorable Risk Hodgkin Lymphoma

  2014cited by this paper
• An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma.

  2013cited by this paper
• Modifiable risk factors and major cardiac events among adult survivors of childhood cancer.

  2013cited by this paper
• Clinical Investigation : Lymphoma Involved Node Radiation Therapy : An Effective Alternative in Early-Stage Hodgkin Lymphoma

  2013cited by this paper
• Changes in breast cancer risk associated with different volumes, doses, and techniques in female Hodgkin lymphoma patients treated with supra-diaphragmatic radiation therapy.

  2013cited by this paper
• Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology Group.

  2012cited by this paper
• Treatment of Stage I-II A Non-Bulky Hodgkin's Lymphoma (HL): An Individual Patient-Data Comparison of German Hodgkin Study Group (GHSG) HD10 and HD11 Combined-Modality Therapy (CMT) and NCIC Clinical Trials Group (NCIC CTG) HD.6 ABVD Alone

  2012cited by this paper
• Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort

  2011cited by this paper
• Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients.

  2010cited by this paper
• Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort

  2009cited by this paper
• Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.

  2008cited by this paper
• A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk

  2007cited by this paper
• Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma

  2007cited by this paper
• Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines.

  2006cited by this paper
• Pediatric Hodgkin's disease.

  2004cited by this paper
• Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.

  2003cited by this paper
• The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.

  1984cited by this paper
• Hematologic neoplasia in patients treated for Hodgkin's disease.

  1977cited by this paper
• Pediatric Hodgkin's disease. II. Results of therapy

  1976cited by this paper
• Extended-field radical radiotherapy in advanced Hodgkin's disease: short-term results of 2 randomized clinical trials.

  1966cited by this paper
• Clinical Investigation : Lymphoma Involved-Site Image-Guided Intensity Modulated Versus 3 D Conformal Radiation Therapy in Early Stage Supradiaphragmatic Hodgkin Lymphoma

  year unknowncited by this paper

• Anticancer property of β-sitosterol studied in MG 63 Osteosarcoma cell line

  2025cites this paper
• Long-Term Results of IFRT vs. ISRT in Infradiaphragmal Fields in Aggressive Non-Hodgkins’s Lymphoma Patients—A Single Centre Experience

  2024cites this paper
• Hodkgin lymphoma concomitant of tuberculosis, a therapeutic challenge for multidisciplinary management.

  2020cites this paper
• Relapsed, Refractory, or Advanced Hodgkin Lymphoma: A Single-Center Experience.

  2020cites this paper
• Radiotherapeutic implications of the updated ICRP thresholds for tissue reactions related to cataracts and circulatory diseases

  2018cites this paper
• Clinical Evaluation and Management of Hodgkin Lymphoma

  2018cites this paper